The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Trastuzumab treatment in patients with advanced breast cancer (ABC) confined to locoregional and skeletal sites: Results from a large noninterventional study.
Christian Jackisch
Consultant or Advisory Role - Roche
Honoraria - Roche
Winfried Schoenegg
No relevant relationships to disclose
Johannes Selbach
No relevant relationships to disclose
Manfred Welslau
No relevant relationships to disclose
Hanns-Detlev Harich
No relevant relationships to disclose
Jan Schroeder
No relevant relationships to disclose
Marcus Schmidt
No relevant relationships to disclose
Thomas Goehler
No relevant relationships to disclose
Axel Hinke
Research Funding - Roche
Heidi Eustermann
No relevant relationships to disclose
Ralf Ringel
No relevant relationships to disclose